HealthcareServices

Gene Therapy Clinical Trial Services Market Forecast 2026–2035: How to Leverage Market Growth

February 27, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the gene therapy clinical trial services market from 2026–2035 with trusted insights from The Business Research Company

What is the expected shift in the Gene Therapy Clinical Trial Services Market’s size between 2026 and 2030?

The gene therapy clinical trial services market size has experienced rapid expansion in recent years. It is forecast to increase from $1.82 billion in 2025 to $2.18 billion in 2026, achieving a compound annual growth rate (CAGR) of 19.4%. The market’s historical growth can be ascribed to several factors, including escalating investment in gene therapy research and development, the expansion of early-stage gene therapy pipelines, growing collaboration between biotechnology firms and contract research organizations (CROs), the increasing complexity of gene therapy trial protocols, and heightened regulatory scrutiny of advanced therapies.

The gene therapy clinical trial services market is projected to experience substantial growth in the upcoming years. It is anticipated to expand to $4.39 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 19.1%. This expansion during the forecast period can be attributed to an increasing number of late-stage gene therapy trials, a rising need for global trial execution capabilities, the broadening of rare disease gene therapy programs, the growing utilization of digital trial management platforms, and an intensifying focus on accelerated regulatory approvals. Significant trends for the forecast period include an increasing demand for specialized gene therapy trial management, the rising adoption of decentralized and hybrid trial models, a growing emphasis on advanced cold chain and logistics support, the expansion of patient-centric trial design approaches, and an enhanced focus on regulatory and data integrity services.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27292&type=smp

Which Drivers Are Shaping Strategic Decisions In The Gene Therapy Clinical Trial Services Market?

The increasing requirement for personalized medicine is projected to stimulate the growth of the gene therapy clinical trial services market moving forward. Personalized medicine is a method that adapts medical treatment to distinct individual attributes, including genetic, biomarker, and lifestyle elements. The demand for personalized medicine is escalating due to progress in genomics and biotechnology, which facilitate more accurate targeting of therapies. Gene therapy clinical trial services aid personalized medicine by analyzing patient-specific genetic profiles and customizing treatments accordingly, employing biomarker analysis and companion diagnostics to optimize therapy for each individual while boosting safety and effectiveness. For instance, in February 2024, the Personalized Medicine Coalition, a US-based hospital and health care organization, reported that in 2023, the FDA approved 16 new personalized treatments for rare disease patients, an increase from six in 2022. Consequently, the rising demand for personalized medicine is propelling the growth of the gene therapy clinical trial services market.

What Segment Classifications Make Up The Gene Therapy Clinical Trial Services Market?

The gene therapy clinical trial services market covered in this report is segmented –

1) By Type: Clinical Trial Design And Planning, Supply And Logistics Services, Regulatory Services, Data Management And Biostatistics, Site Management And Monitoring, Other Types

2) By Application: Oncology, Hematology, Endocrine or Metabolic Disorders, Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Applications

3) By End-User: Pharmaceutical Companies, Biotechnology Companies, Academic Institutions, Government Research Institutes, Contract Research Organizations (CROs)

Subsegments:

1) By Clinical Trial Design And Planning: Protocol Development, Feasibility Studies, Patient Recruitment Strategy Design

2) By Supply And Logistics Services: Cold Chain Management, Investigational Product Packaging And Labeling, Controlled-Temperature Storage

3) By Regulatory Services: Regulatory Consulting And Strategy, Ethics Committee Submissions, Regulatory Compliance Monitoring

4) By Data Management And Biostatistics: Clinical Data Capture And Database Design, Data Validation And Quality Control, Statistical Analysis And Modeling

5) By Site Management And Monitoring: Site Selection And Qualification, Investigator Training And Support, On-Site Monitoring Visits

6) By Other Types: Pharmacovigilance And Safety Reporting, Quality Assurance And Auditing, Patient Engagement And Retention

Which Trends Are Influencing The Performance And Direction Of The Gene Therapy Clinical Trial Services Market?

Major companies operating in the gene therapy clinical trial services market are prioritizing the development of innovative solutions, such as the long-term follow-up (LTFU) model for cell and gene therapy (CGT) trials, to accelerate the overall trial process while maintaining regulatory compliance and safety standards. A Long-Term Follow-Up (LTFU) model for cell and gene therapy (CGT) trials is a structured framework designed to monitor patients over an extended period, often up to 15 years after receiving a CGT treatment. For instance, in May 2025, Medable Inc., a US-based SaaS company, launched a digital-first Long-Term Follow-Up (LTFU) model specifically designed for cell and gene therapy (CGT) trials. It supports cell and gene therapy trials by reducing patient and site burdens while ensuring scientific rigor over the FDA-required 15-year monitoring period. The model improves patient access, retention, and data continuity through remote and hybrid follow-up methods, enhancing long-term safety and efficacy monitoring.

Which Major Firms Are Strengthening Their Position In The Gene Therapy Clinical Trial Services Market?

Major companies operating in the gene therapy clinical trial services market are Thermo Fisher Scientific Inc., Sharp Services LLC, Labcorp, Pharmaceutical Product Development LLC, ICON plc, Syneos Health Inc., WuXi AppTec, Franklin Biolabs, Catalent Inc., Charles River Laboratories International Inc., Parexel International Corporation, Medpace Holdings Inc., Precision Medicine Group LLC, Worldwide Clinical Trials, IQVIA Holdings Inc., TFS HealthScience, Veristat LLC, Novotech Health Holdings Pte Limited, Covance Inc., PPD Clinical Research Services, PRA Health Sciences Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/gene-therapy-clinical-trial-services-global-market-report

Which Global Regions Are Shaping The Competitive Landscape Of The Gene Therapy Clinical Trial Services Market?

North America was the largest region in the gene therapy clinical trial services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gene therapy clinical trial services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Gene Therapy Clinical Trial Services Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27292&type=smp

Browse Through More Reports Similar to the Global Gene Therapy Clinical Trial Services Market 2026, By The Business Research Company

Ranibizumab Market Report 2026

https://www.thebusinessresearchcompany.com/report/ranibizumab-global-market-report

Nitrobenzene Market Report 2026

https://www.thebusinessresearchcompany.com/report/nitrobenzene-global-market-report

Triazole Fungicides Market Report 2026

https://www.thebusinessresearchcompany.com/report/triazole-fungicides-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795